Benzinga · Sep 18, 2026
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115
Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.
NASDAQ · HQY
Healthcare · Medical - Healthcare Information Services
$91.75
Down-$1.36 (-1.48%)
Updated Sep 23, 2026, 10:29 PM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
HQY closed at $91.75 after 20 trading sessions, down 12.94% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $95.77 | $95.97 | $91.2814 | $91.75 | 1.22M |
| Sep 21, 2026 | $95.45 | $95.97 | $94.39 | $94.52 | 655.65K |
| Sep 18, 2026 | $94.87 | $95.575 | $93.47 | $95.14 | 1.3M |
| Sep 17, 2026 | $96.23 | $96.23 | $93.7021 | $94.51 | 657.89K |
| Sep 16, 2026 | $96.00 | $97.92 | $95.545 | $96.00 | 688.36K |
| Sep 15, 2026 | $96.00 | $96.99 | $95.30 | $96.51 | 1.12M |
| Sep 14, 2026 | $97.57 | $98.02 | $95.34 | $96.04 | 1.09M |
| Sep 11, 2026 | $95.51 | $96.69 | $94.41 | $96.26 | 652.36K |
| Sep 10, 2026 | $92.85 | $94.68 | $92.85 | $94.55 | 685.1K |
| Sep 9, 2026 | $92.49 | $94.60 | $91.32 | $92.66 | 693.92K |
| Sep 8, 2026 | $95.54 | $95.54 | $93.09 | $93.36 | 873K |
| Sep 4, 2026 | $97.03 | $97.4118 | $95.57 | $96.07 | 432.49K |
| Sep 3, 2026 | $98.84 | $99.21 | $97.825 | $98.78 | 443.44K |
| Sep 2, 2026 | $97.63 | $99.775 | $96.65 | $98.54 | 784.53K |
| Sep 1, 2026 | $96.65 | $98.65 | $96.035 | $97.00 | 870.66K |
| Aug 31, 2026 | $95.55 | $96.86 | $93.06 | $96.54 | 842.01K |
| Aug 28, 2026 | $93.62 | $97.99 | $92.77 | $96.37 | 2.26M |
| Aug 27, 2026 | $97.16 | $98.1601 | $88.675 | $93.39 | 3.22M |
| Aug 26, 2026 | $104.39 | $106.0223 | $103.56 | $104.42 | 774.54K |
| Aug 25, 2026 | $105.19 | $105.58 | $103.71 | $105.385 | 616.56K |
The latest Smart Investors Daily articles mentioning HQY.
HQY research
Company profile and research snapshot.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 18, 2026 | Barclays | Overweight | — |
| Aug 31, 2026 | Deutsche Bank | Buy | — |
| Aug 28, 2026 | BTIG | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
| Jun 3, 2026 | RBC Capital | Outperform | — |
No generated briefing is available yet.
Benzinga · Sep 18, 2026
Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.
Yahoo · Sep 4, 2026
HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
Yahoo · Sep 1, 2026
HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into […]
Yahoo · Sep 1, 2026
Record profitability and accelerated invested asset growth signal durability.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HQY.